Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05076578 · ClinicalTrials.gov registry record · NA
A Prospective Clinical Study Evaluating the Harvesting of Micografts
A NA study, sponsored by SerenaGroup.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05076578: Completed NA study, sponsored by SerenaGroup.
NCT05076578 is a NA study that has completed, run by SerenaGroup. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05076578, a NA study, has completed, sponsored by SerenaGroup.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
ART (Autologous Regeneration of Tissue) is a revolutionary technology for harvesting skin without the drawbacks of conventional grafting. This innovative system allows the clinician to collect hundreds of microcolumns of full-thickness skin tissue and apply them directly to the wound site. It can all be done in an outpatient setting with minimized donor site concerns.
Primary Outcome
Evaluating Wound Closure with Surface area through measurments
Interventions
- DEVICE Autologous Regeneration of Tissue (ARTTM) system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-09-13 |
| Est. Completion | 2022-02-01 |
| Phase | NA |
What the finished NCT05076578 record still lists
NCT05076578 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Autologous Regeneration of Tissue (ARTTM) system is the first listed.
NCT05076578 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05076578 about?
NCT05076578 is a clinical study titled "A Prospective Clinical Study Evaluating the Harvesting of Micografts". ART (Autologous Regeneration of Tissue) is a revolutionary technology for harvesting skin without the drawbacks of conventional grafting. This innovative system allows the clinician to collect hundreds of microcolumns of full-thickness skin tissue and apply them directly to the wound site. It can al...
What is the current status of trial NCT05076578?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-09-13. Estimated completion is 2022-02-01.
What interventions are being tested in trial NCT05076578?
The interventions under investigation include: Autologous Regeneration of Tissue (ARTTM) system (DEVICE).
Who is sponsoring clinical trial NCT05076578?
This trial is sponsored by SerenaGroup, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05076578's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI